At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 81 enrolled
Drug / intervention
Crisaborole ointment 2% +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 2b, Multi Center, Randomized, Double-Blind, Vehicle-Controlled, Intra-Participant Study, to Evaluate Efficacy and Safety of Two Regimens of Crisaborole Ointment 2% in Japanese Pediatric and Adult Participants (2 Years and Older) With Mild to Moderate Atopic Dermatitis
In Brief
A Phase 2 clinical trial evaluating Crisaborole ointment 2% and Vehicle for Atopic Dermatitis. Completed, enrolled 81 participants across 3 sites.
Detailed Summary
This is a Phase 2b, multi-center, randomized, double-blind, vehicle-controlled, intraparticipant study to evaluate efficacy and safety of two regimens of crisaborole ointment 2% in Japanese pediatric and adult participants (cohort 1: 12 years and older, cohort 2: 2 to under 12 years old) with mild to moderate Atopic Dermatitis (AD).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtopic Dermatitis
CountriesJapan
Collaborators--
Timeline
Phase 2CompletedFinished
2020202120222023202420252026
First PostedMay 2019
Enrollment StartJun 2019
Primary CompletionDec 2019
TodayJul 2026
First PostedMay 17, 2019
Enrollment StartJun 15, 2019
Primary CompletionDec 16, 2019
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 7.1 years ago
Interventions
Crisaborole ointment 2%drug
BID regimen
Vehicledrug
BID regimen
Crisaborole ointment 2%drug
QD regimen
Vehicledrug
QD regimen